CentralCharts: Supercharge your portfolio with groundbreaking tools.

NexGen Announces Additional Mineralization Discovered at Patterson Corridor East, Assays from RK-24-183 and Commencement of Expanded Summer Exploration Program PR Newswire VANCOUVER, BC, May 29, 2024 VANCOUVER, BC , May 29, 2024 /PRNewswire/ - NexGen Energy Ltd. ("NexGen" or the "Company") (TSX: NXE) (NYSE: NXE) (ASX: NXG) is pleased to announce drilling at Patterson Corridor East (" PCE ") has intersected mineralization in RK-24-193 over 67.5 metres (m) (383.5 to 451 m ) across various...

Talos Energy Announces Participation at Upcoming Investor Conferences and Webcast of Fireside Chats PR Newswire HOUSTON, May 29, 2024 HOUSTON , May 29, 2024 /PRNewswire/ -- Talos Energy Inc. (NYSE: TALO) ("Talos" or the "Company") today announced that representatives of Talos will participate at the following investor conferences and fireside chats. RBC Capital Markets Global Energy, Power and Infrastructure Conference in New York, New York , June 4, 2024 . Bank of America Energy Credit...

WINSTON-SALEM, N.C., May 29, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that senior members of the management team will be participating in the Jefferies Global Healthcare Conference taking place from June 4 – 6, 2024 in New York, NY. The ProKidney management team will host one-on-one meetings during the event. Interested investors should contact...

BURLINGTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes (T2D), today announced that it will present new preclinical obesity data from its pancreatic gene therapy platform, Rejuva, at the upcoming American Diabetes Association (ADA)’s 84 th Scientific Sessions taking place June 21-24, 2024 in Orlando, FL. The abstract,...

BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea, will present a business update at the Jefferies Healthcare Conference on Wednesday, June 5, 2024 at 10:30 a.m. ET in New York. A live webcast of the presentation...

Company Committed to Maximizing Value for All Shareholders; Strategic Alternatives Process Underway Reaffirms Confidence in Business and Guidance of 21 EH/s and 21 w/TH in 2024 This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 8, 2024, to its short form base shelf prospectus dated November 10, 2023. TORONTO, Ontario and BROSSARD, Québec, May 29, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (Nasdaq/TSX: BITF)...

NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Marpai, Inc. (OTCQX: MRAI), an independent national Third-Party Administration (TPA) company, has qualified to trade on the OTCQX® Best Market. Marpai, Inc. previously traded on NASDAQ. Marpai, Inc. begins trading today on OTCQX under the symbol “MRAI.” U.S. investors can find current financial disclosure and...

SOUTH SAN FRANCISCO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that management will present at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 4:00 p.m. E.T. in New York, NY. A live webcast of the Company presentation will be available through the investor relations section...